West Historical Income Statement

WST Stock  USD 325.68  2.36  0.73%   
Historical analysis of West Pharmaceutical income statement accounts such as Depreciation And Amortization of 144.2 M, Total Revenue of 3.1 B, Gross Profit of 1.2 B or Other Operating Expenses of 2.4 B can show how well West Pharmaceutical Services performed in making a profits. Evaluating West Pharmaceutical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of West Pharmaceutical's future profits or losses.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining West Pharmaceutical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether West Pharmaceutical is a good buy for the upcoming year.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About West Income Statement Analysis

West Pharmaceutical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to West Pharmaceutical shareholders. The income statement also shows West investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

West Pharmaceutical Income Statement Chart

At this time, West Pharmaceutical's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 732.9 M in 2024, despite the fact that Non Operating Income Net Other is likely to grow to (27.9 M).

Total Revenue

Total revenue comprises all receipts West Pharmaceutical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of West Pharmaceutical Services minus its cost of goods sold. It is profit before West Pharmaceutical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of West Pharmaceutical. It is also known as West Pharmaceutical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from West Pharmaceutical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of West Pharmaceutical Services is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Minority Interest

Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of West Pharmaceutical Services whose combined shares represent less than 50% of the total outstanding shares issued by West Pharmaceutical have a minority interest in West Pharmaceutical.
Most accounts from West Pharmaceutical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into West Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
At this time, West Pharmaceutical's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 732.9 M in 2024, despite the fact that Non Operating Income Net Other is likely to grow to (27.9 M).
 2021 2022 2023 2024 (projected)
Total Revenue2.8B2.9B2.9B3.1B
Depreciation And Amortization122.3M120.6M137.3M144.2M

West Pharmaceutical income statement Correlations

0.950.90.980.820.80.840.970.990.830.130.820.850.040.780.910.79-0.370.730.250.60.75
0.950.990.990.960.950.960.990.980.960.120.950.95-0.110.770.960.94-0.470.860.290.650.89
0.90.990.970.990.980.990.970.950.990.120.980.95-0.170.750.950.97-0.470.890.30.640.92
0.980.990.970.920.90.931.00.990.920.130.910.92-0.050.780.960.89-0.450.820.280.640.85
0.820.960.990.920.990.990.930.891.00.141.00.95-0.240.710.930.99-0.480.910.290.620.93
0.80.950.980.90.991.00.910.870.990.120.990.96-0.270.690.920.99-0.490.920.310.630.92
0.840.960.990.930.991.00.930.90.990.130.990.96-0.240.710.940.99-0.480.910.30.640.92
0.970.990.971.00.930.910.930.990.930.130.920.93-0.060.780.960.9-0.460.830.280.650.85
0.990.980.950.990.890.870.90.990.890.140.880.90.010.790.940.86-0.410.780.30.630.82
0.830.960.990.921.00.990.990.930.890.191.00.95-0.270.690.941.0-0.480.910.330.660.95
0.130.120.120.130.140.120.130.130.140.190.180.22-0.19-0.130.260.2-0.080.110.490.490.3
0.820.950.980.911.00.990.990.920.881.00.180.94-0.260.690.921.0-0.460.90.330.640.95
0.850.950.950.920.950.960.960.930.90.950.220.94-0.260.660.950.93-0.530.930.30.690.88
0.04-0.11-0.17-0.05-0.24-0.27-0.24-0.060.01-0.27-0.19-0.26-0.260.06-0.13-0.29-0.03-0.370.18-0.14-0.25
0.780.770.750.780.710.690.710.780.790.69-0.130.690.660.060.640.65-0.070.73-0.140.170.62
0.910.960.950.960.930.920.940.960.940.940.260.920.95-0.130.640.92-0.620.830.480.810.91
0.790.940.970.890.990.990.990.90.861.00.21.00.93-0.290.650.92-0.480.890.360.670.96
-0.37-0.47-0.47-0.45-0.48-0.49-0.48-0.46-0.41-0.48-0.08-0.46-0.53-0.03-0.07-0.62-0.48-0.43-0.64-0.79-0.59
0.730.860.890.820.910.920.910.830.780.910.110.90.93-0.370.730.830.89-0.430.120.550.87
0.250.290.30.280.290.310.30.280.30.330.490.330.30.18-0.140.480.36-0.640.120.810.5
0.60.650.640.640.620.630.640.650.630.660.490.640.69-0.140.170.810.67-0.790.550.810.78
0.750.890.920.850.930.920.920.850.820.950.30.950.88-0.250.620.910.96-0.590.870.50.78
Click cells to compare fundamentals

West Pharmaceutical Account Relationship Matchups

West Pharmaceutical income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization103.3M109.1M122.3M120.6M137.3M144.2M
Total Revenue1.8B2.1B2.8B2.9B2.9B3.1B
Gross Profit605.7M767.8M1.2B1.1B1.1B1.2B
Other Operating Expenses1.5B1.7B2.1B2.2B2.3B2.4B
Operating Income296.6M406.9M752.3M734M676M709.8M
Ebit296.6M422.6M772.9M767.3M706.8M742.1M
Ebitda399.9M531.7M895.2M887.9M844.1M886.3M
Cost Of Revenue1.2B1.4B1.7B1.8B1.8B1.9B
Total Operating Expenses311.6M360.9M423.5M402.2M454M476.7M
Income Before Tax291.8M401.3M748.9M679.9M698M732.9M
Total Other Income Expense Net(4.8M)(5.6M)(3.4M)(54.1M)22M23.1M
Net Income241.7M346.2M661.8M585.9M593.4M623.1M
Income Tax Expense59M72.5M107.2M114.7M122.3M128.4M
Interest Expense4.7M6.8M7.2M7.9M9M6.5M
Selling General Administrative272.7M302M362.8M343.7M353.4M194.7M
Research Development38.9M46.9M52.8M58.5M68.4M71.8M
Net Income Applicable To Common Shares232.8M346.2M661.8M585.9M673.8M707.5M
Net Income From Continuing Ops232.8M328.8M641.7M565.2M593.4M623.1M
Non Operating Income Net Other12.6M20M24.9M(25.5M)(29.3M)(27.9M)
Tax Provision59M72.5M107.2M114.7M122.3M83.0M
Interest Income3.8M6.8M7.2M2.8M28M29.4M
Extraordinary Items(81.9M)2.5M1.4M5.7M6.6M6.9M
Net Interest Income(4.7M)(6.8M)(7.2M)(2.8M)19M20.0M
Reconciled Depreciation103.4M109.1M122.3M120.6M137.3M124.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.